We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Diabetes

Journal Scan / Research · November 06, 2014

Superior Glycemic Efficacy With Dapagliflozin vs Glipizide in T2DM With Poor Glycemic Control on Metformin Alone

Diabetes, Obesity & Metabolism

 

Additional Info

Diabetes, Obesity & Metabolism
Durability of Glycaemic Efficacy Over 2 Years With Dapagliflozin Versus Glipizide as Add-On Therapies in Patients Whose Type 2 Diabetes Mellitus Is Inadequately Controlled With Metformin
Diabetes Obes Metab 2014 Nov 01;16(11)1111-1120, MA Nauck, S Del Prato, S Durán-García, K Rohwedder, AM Langkilde, J Sugg, SJ Parikh

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading